Skip to main content
Weight loss after Roux-en-Y gastric bypass in obese patients heterozygous for MC4R mutations.
- Author(s): Aslan, Ivy R;
- Campos, Guilherme M;
- Calton, Melissa A;
- Evans, Daniel S;
- Merriman, Raphael B;
- Vaisse, Christian
- et al.
Published Web Locationhttps://doi.org/10.1007/s11695-010-0295-8
BackgroundHeterozygous mutations in melanocortin-4 receptor (MC4R) are the most frequent genetic cause of obesity. Bariatric surgery is a successful treatment for severe obesity. The mechanisms of weight loss after bariatric surgery are not well understood.
MethodsNinety-two patients who had Roux-en-Y gastric bypass (RYGB) surgery were screened for MC4R mutations. We compared percent excess weight loss (%EWL) in the four MC4R mutation carriers with that of two control groups: 8 matched controls and with the remaining 80 patients who underwent RYGB.
ResultsFour patients were heterozygous for functionally significant MC4R mutations. In patients with MC4R mutations, the %EWL after RYGB (66% EWL) was not significantly different compared to matched controls (70% EWL) and non-matched controls (60% EWL) after 1 year of follow-up.
ConclusionsThis study suggests that patients with heterozygous MC4R mutations also benefit from RYGB and that weight loss may be independent of the presence of such mutations.
For improved accessibility of PDF content, download the file to your device.